Cholesterol-lowering drugs may boost bones.
Vogel
G
G
D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D015519:Bone Density / Q000187:drug effects*; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000096:biosynthesis; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D008148:Lovastatin / Q000494:pharmacology*; D051379:Mice; D010012:Osteogenesis / Q000187:drug effects*; D010024:Osteoporosis / Q000188:drug therapy; D051381:Rats; D019821:Simvastatin / Q000494:pharmacology; D016212:Transforming Growth Factor beta
D000924:Anticholesteremic Agents; C525718:BMP2 protein, human; C525719:Bmp2 protein, mouse; C525720:Bmp2 protein, rat; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D016212:Transforming Growth Factor beta; D008148:Lovastatin; D019821:Simvastatin